Back to search results

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Abroad (travel likely)Recruiting

Conditions

Cancer · Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Tom Baker Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Patricia Tang, MD) · Patricia.Tang@albertahealthservices.ca · 403-521-3723

  • Cross Cancer Institute, Edmonton, Alberta, Canada

  • BC Cancer - Vancouver, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Daniel J Renouf, MD) · drenouf@bccancer.bc.ca · 6048776000
    Howard Lim, MD (Sub-investigator)
    Janine M Davies, MD (Sub-investigator)
    Sharlene Gill, MD (Sub-investigator)

  • The Ottawa Hospital, Ottawa, Ontario, Canada

Study leads

  • Daniel J Renouf, MD

    Principal Investigator

    BC Cancer

View source on ClinicalTrials.gov(opens in a new tab)